Clinical Trial Details

EORTC-1320

Back to Clinical Trials Database

Trabectedin for recurrent grade II or III meningioma: a randomized phase II study of the EORTC Brain Tumor Group

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 10-Jul-2015
Date Step1 close: 20-Jul-2017
Data management at EORTC Yes
Design Phase 2
Randomized open label
Targeted Sample size EORTC Groups: 86 - All Groups: 86
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/ct/show/NCT02234050
NCT number NCT02234050
EudraCT 2014-002446-47